Biomerica, Inc. (BMRA | DoD: -0.95% | YTD: +29.13% | SmallCap: 9M)

• Profile: A biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide
• Reporting: Biomerica Reports Fiscal 2025 Year End Results (Full Text)

STAAR Surgical Company (STAA | DoD: -0.15% | YTD: +13.53% | SmallCap: 858M)

• Profile: The global leader in vision correction technology
• Acquisition: Broadwood Announces Intent to Vote Against Acquisition of STAAR Surgical by Alcon (Full Text)

Sharps Technology, Inc. (STSS | DoD: -15.47% | YTD: -97.86% | SmallCap: 4M)

• Profile: A medical device and pharmaceutical packaging company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products
• Acquisition: Sharps Technology, Inc. Acquires Over 2 Million SOL, the Native Asset of Solana, the Fastest and Most Used Public Blockchain (Full Text)

Solventum Corporation (SOLV | DoD: +0.59% | YTD: +10.86% | MidCap: 12.8B)

• Profile: A healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs
• Acquisition: Solventum Completes Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. (Full Text)

Solventum Corporation (SOLV | DoD: +0.59% | YTD: +10.86% | MidCap: 12.8B)

• Profile: A healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs
• Acquisition: Thermo Fisher Scientific Completes Acquisition of Solventum's Purification and Filtration Business (Full Text)

Thermo Fisher Scientific Inc. (TMO | DoD: +0.61% | YTD: -5.53% | LargeCap: 148.8B)

• Profile: Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services
• Acquisition: Thermo Fisher Scientific Completes Acquisition of Sanofi's Ridgefield, New Jersey Site (Full Text)

Agilent Technologies, Inc. (A | DoD: +0.56% | YTD: -5.42% | LargeCap: 32.1B)

• Profile: Provider of application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide
• Regulatory: Agilent's MMR IHC Panel pharmDx (Dako Omnis) Receives European IVDR Certification as a Companion Diagnostic Test for Colorectal Cancer (Full Text)

Hyperfine, Inc. (HYPR | DoD: +0.00% | YTD: +26.53% | SmallCap: 64M)

• Profile: A health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system
• Regulatory: Hyperfine Receives CE Mark and UKCA Approval for Optive AI™ Software, Expanding Global Commercialization of Latest AI-Powered Imaging Software (Full Text)

Johnson & Johnson (JNJ | DoD: +0.98% | YTD: +25.97% | LargeCap: 373.9B)

• Profile: Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide
• Clinical: Johnson & Johnson Unveils Results from the VARIPURE Substudy of SECURE, a Real-World Study on VARIPULSE™ Platform, at 2025 European Society of Cardiology (ESC) Congress (Full Text)

Johnson & Johnson (JNJ | DoD: +0.98% | YTD: +25.97% | LargeCap: 373.9B)

• Profile: Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide
• Clinical: New Data from the DanGer Shock Randomized Control Trial, Published in The New England Journal of Medicine, Confirms the Long-Term Survival Benefit of the Impella CP Heart Pump (Full Text)

Mainz Biomed N.V. (MYNZ | DoD: +1.82% | YTD: -60.93% | SmallCap: 8M)

• Profile: Develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer
• Regulatory: Mainz Biomed Announces Registration of ColoAlert in the United Kingdom (Full Text)

Medtronic plc (MDT | DoD: +0.92% | YTD: +17.58% | LargeCap: 108.8B)

• Profile: A global leader in healthcare technology
• FDA Clearance: FDA Clears MiniMed™ 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes (Full Text)

Pulse Biosciences, Inc. (PLSE | DoD: -0.13% | YTD: -12.65% | MidCap: 1.1B)

• Profile: Operates as a novel bioelectric medicine company
• Clinical: Pulse Biosciences Announces First Successful Procedures in PRECISE Benign Thyroid Nodule (BTN) Study (Full Text)

Qiagen N.V. (QGEN | DoD: +0.78% | YTD: +4.98% | MidCap: 9.8B)

• Profile: Provides sample to insight solutions that transform biological samples into molecular insights
• FDA Clearance: QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic Testing (Full Text)

Quest Diagnostics Incorporated (DGX | DoD: +1.36% | YTD: +22.06% | MidCap: 19.3B)

• Profile: A leading provider of diagnostic information services
• Clinical: Fentanyl Positivity Is More Than Seven Times Higher in Random Tests vs. Pre-Employment Drug Screening, Finds 2025 Quest Diagnostics Drug Testing Index (Full Text)

Revvity, Inc. (RVTY | DoD: +0.99% | YTD: -19.38% | MidCap: 10.5B)

• Profile: Provides health sciences solutions, technologies, and services worldwide
• Product: Revvity Establishes In Vivo Imaging Center of Excellence in North Carolina (Full Text)

Stereotaxis, Inc. (STXS | DoD: +2.49% | YTD: +25.76% | SmallCap: 193M)

• Profile: A pioneer and global leader in surgical robotics for minimally invasive endovascular intervention
• Product: First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter (Full Text)

Twist Bioscience Corporation (TWST | DoD: +1.43% | YTD: -40.48% | MidCap: 1.9B)

• Profile: Manufactures and sells synthetic DNA-based products
• Collaboration: Twist Bioscience Collaborates with Synthetic Design Lab (Full Text)

Zentek Ltd. (ZTEK | DoD: +0.00% | YTD: -31.58% | SmallCap: 159M)

• Profile: Engages in the research and development of graphene and related nanomaterials
• Partnership: Zentek Subsidiary Albany Graphite Corp. Awarded $500,000 Critical Minerals Innovation Fund Grant for Purification and Anode Development Project (Full Text)

Becton, Dickinson and Company (BDX | DoD: +0.90% | YTD: -13.89% | LargeCap: 48.6B)

• Profile: A leading global medical technology company
• Event: BD Expands Peripheral Artery Disease Awareness Efforts with 'Love Your Limbs' Community Screening Initiative (Full Text)

Daxor Corporation (DXR | DoD: -2.48% | YTD: +45.70% | SmallCap: 41M)

• Profile: The global leader in blood volume measurement technology
• Report: Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter (Full Text)

GRAIL, Inc. (GRAL | DoD: -3.87% | YTD: +82.98% | MidCap: 1.4B)

• Profile: A commercial-stage healthcare company, provides multi-cancer early detection testing and services
• Announcement: GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (Full Text)

Trinity Biotech plc (TRIB | DoD: -5.19% | YTD: +53.70% | SmallCap: 1M)

• Profile: Develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market
• Announcement: Trinity Biotech Regains Compliance with Nasdaq Listing Requirements (Full Text)

GeneDx Holdings Corp. (WGS | DoD: +0.38% | YTD: +62.61% | MidCap: 2.1B)

• Profile: Maker of industry-leading exome and genome tests that translate complex genomic data into clinical answers
• Leadership Update: Seer Appoints Isaac Ro to its Board of Directors (Full Text)

IQVIA Holdings Inc. (IQV | DoD: +1.10% | YTD: -2.21% | MidCap: 24.4B)

• Profile: Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries
• Leadership Update: IQVIA Announces CFO Transition in Early 2026 (Full Text)